@article{500dba7ad5bc4d76862b4e648a714f8e,
title = "Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients",
abstract = "Although most patients with gastro-oesophageal reflux disease (GERD) benefit from proton pump inhibitor (PPI) therapy, some experience only partial symptom relief.",
keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Adult, Esomeprazole Sodium, Esophagitis, Peptic, Female, Gastroesophageal Reflux, Humans, Male, Middle Aged, Omeprazole, Proton Pump Inhibitors, Quality of Life, Randomized Controlled Trials as Topic, Severity of Illness Index, Time Factors, Treatment Outcome",
author = "P Bytzer and {van Zanten}, {S Veldhuyzen} and H Mattsson and B Wernersson",
note = "{\textcopyright} 2012 Blackwell Publishing Ltd.",
year = "2012",
month = oct,
doi = "10.1111/apt.12007",
language = "English",
volume = "36",
pages = "635--43",
journal = "Alimentary Pharmacology and Therapeutics, Supplement",
issn = "0953-0673",
publisher = "Wiley-Blackwell",
number = "7",
}